Arno Therapeutics
ARNI · OTC
$0.0001+$0.0001 (+0.00%)TodayMarket closed ·
No price history for this range.
Key indicators
ARNI profitability and balance sheet ratios
Return on equity -207.8% in Dec 2011, down 199.6 points on a year earlier.
| Period | Return on equity |
|---|---|
| Dec 2010 | -8.2% |
| Mar 2011 | -40.5% |
| Jun 2011 | -73.9% |
| Sep 2011 | -116.5% |
| Dec 2011 | -207.8% |
Income statement
No financial statements are reported for Arno Therapeutics.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Mar 2016 | Jun 2016 | Sep 2016 |
|---|---|---|---|
| Total assets | $2.9M | $1.1M | $2.4M |
| Total liabilities | $6.9M | $6.3M | $8.1M |
| Shareholder equity | −$4.0M | −$5.2M | −$5.7M |
| Cash and short-term investments | $2.7M | $0.9M | $2.1M |
| Total debt | $0.0M | $0.0M | $0.0M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.